Paper17501757
Therapeutic issues in HIV/HCV-coinfected patients.
Sulkowski MS and 1 other. J Viral Hepat, 2007. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic issues in HIV/HCV-coinfected patients. Papers, record 17501757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17501757
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| HIV | Major topic |
| HIV Infections | Major topic |
| Hepatitis C | Major topic |
| Interferon-alpha | Major topic |
| Polyethylene Glycols | Major topic |
| Ribavirin | Major topic |
| Anemia | |
| Chemical and Drug Induced Liver Injury | |
| Disease Progression | |
| Drug Therapy, Combination | |
| Humans | |
| Interferon alpha-2 | |
| Leukopenia | |
| Liver Cirrhosis | |
| Liver Transplantation | |
| Mitochondrial Diseases | |
| Recombinant Proteins | |
| Treatment Outcome |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R37 DA013806 | NIDA NIH HHS | United States | R01DA013806 | PubMed and NIH | NIH RePORTER |
| DA-13806 | NIDA NIH HHS | United States | R01DA013806 | PubMed and NIH | NIH RePORTER |
| DA-16065 | NIDA NIH HHS | United States | R01DA016065 | PubMed and NIH | NIH RePORTER |
| R01 DA016065 | NIDA NIH HHS | United States | R01DA016065 | PubMed and NIH | NIH RePORTER |
| R01 DA013806 | NIDA NIH HHS | United States | R01DA013806 | PubMed and NIH | NIH RePORTER |
| R37DA013806 | NIH | NIH RePORTER |
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15828854 | Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15828854 | PubMed |
| 2 | 11197250 | Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. | Am J Gastroenterol | 2001 | https://conductscience.org/library/papers/11197250 | PubMed |
| 3 | 12095384 | Hepatitis C and progression of HIV disease. | JAMA | 2002 | https://conductscience.org/library/papers/12095384 | PubMed |
| 4 | 15282352 | Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15282352 | PubMed |
| 5 | 12879995 | Antiretroviral-associated liver injury. | Clin Liver Dis | 2003 | https://conductscience.org/library/papers/12879995 | PubMed |
| 6 | 3435108 | Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3435108 | PubMed |
| 7 | 16207569 | HIV and liver diseases: recent clinical advances. | Clin Liver Dis | 2005 | https://conductscience.org/library/papers/16207569 | PubMed |
| 8 | 15117326 | Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection. | J Viral Hepat | 2004 | https://conductscience.org/library/papers/15117326 | PubMed |
| 9 | 11786975 | Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. | Hepatology | 2002 | https://conductscience.org/library/papers/11786975 | PubMed |
| 10 | 15972867 | Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15972867 | PubMed |
| 11 | 10632283 | Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. | JAMA | 2000 | https://conductscience.org/library/papers/10632283 | PubMed |
| 12 | 8627819 | Characterization of long-term cultures of hepatitis C virus. | J Virol | 1996 | https://conductscience.org/library/papers/8627819 | PubMed |
| 13 | 15057903 | Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon alpha-2b+ full-course vs. 16-week delayed ribavirin. | Hepatology | 2004 | https://conductscience.org/library/papers/15057903 | PubMed |
| 14 | 15219554 | HIV and hepatitis C virus co-infection. | Lancet Infect Dis | 2004 | https://conductscience.org/library/papers/15219554 | PubMed |
| 15 | 11214134 | Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. | Lancet | 2001 | https://conductscience.org/library/papers/11214134 | PubMed |
| 16 | 9371165 | Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. | Lancet | 1997 | https://conductscience.org/library/papers/9371165 | PubMed |
| 17 | 15456081 | Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. | Antivir Ther | 2004 | https://conductscience.org/library/papers/15456081 | PubMed |
| 18 | 10669367 | Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. | J Infect Dis | 2000 | https://conductscience.org/library/papers/10669367 | PubMed |
| 19 | 9225024 | Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. | J Gen Virol | 1997 | https://conductscience.org/library/papers/9225024 | PubMed |
| 20 | 9174176 | Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9174176 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41126156 | Hepatitis B vaccination status and associated factors among people living with HIV in Gulu, Uganda: a cross-sectional study. | BMC Public Health | 2025 | https://conductscience.org/library/papers/41126156 | PubMed |
| 36844142 | Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/36844142 | PubMed |
| 35054088 | Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection. | J Clin Med | 2022 | https://conductscience.org/library/papers/35054088 | PubMed |
| 34943573 | Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34943573 | PubMed |
| 28697809 | Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users. | Virol J | 2017 | https://conductscience.org/library/papers/28697809 | PubMed |
| 27830997 | Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes. | Pathog Glob Health | 2016 | https://conductscience.org/library/papers/27830997 | PubMed |
| 27025835 | 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27025835 | PubMed |
| 26511293 | Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease. | J Viral Hepat | 2016 | https://conductscience.org/library/papers/26511293 | PubMed |
| 25769097 | Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam. | Eur J Gastroenterol Hepatol | 2015 | https://conductscience.org/library/papers/25769097 | PubMed |
| 25705565 | Host Genetic Factors and Dendritic Cell Responses Associated with the Outcome of Interferon/Ribavirin Treatment in HIV-1/HCV Co-Infected Individuals. | J Clin Cell Immunol | 2014 | https://conductscience.org/library/papers/25705565 | PubMed |
| 25580050 | Proteomic analysis of serum and urine of HIV-monoinfected and HIV/HCV-coinfected patients undergoing long term treatment with nevirapine. | Dis Markers | 2014 | https://conductscience.org/library/papers/25580050 | PubMed |
| 25007250 | CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals. | PLoS One | 2014 | https://conductscience.org/library/papers/25007250 | PubMed |
| 24650094 | Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/24650094 | PubMed |
| 23691197 | The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting. | PLoS One | 2013 | https://conductscience.org/library/papers/23691197 | PubMed |
| 21606539 | The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21606539 | PubMed |
| 21045598 | Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis. | J Acquir Immune Defic Syndr | 2010 | https://conductscience.org/library/papers/21045598 | PubMed |
| 20555019 | Adjuvant high-dose interferon-{alpha} for resected melanoma in a patient with HIV infection. | Oncologist | 2010 | https://conductscience.org/library/papers/20555019 | PubMed |
| 20523729 | High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China. | PLoS One | 2010 | https://conductscience.org/library/papers/20523729 | PubMed |
| 20142333 | Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report. | Oncologist | 2010 | https://conductscience.org/library/papers/20142333 | PubMed |
| 19853480 | Hepatitis C treatment experiences and decision making among patients living with HIV infection. | J Assoc Nurses AIDS Care | 2010 | https://conductscience.org/library/papers/19853480 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADA | 100 | PubTator's text mining | https://conductscience.org/library/genes/100 | NCBI Gene |
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| BCHE | 590 | PubTator's text mining | https://conductscience.org/library/genes/590 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CSF3 | 1440 | PubTator's text mining | https://conductscience.org/library/genes/1440 | NCBI Gene |
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| POLG | 5428 | PubTator's text mining | https://conductscience.org/library/genes/5428 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17501757
GET https://conductscience.org/api/papers/v1/17501757/references?page=2